Skinvisible Web Sign Up for Updates         T 702.433.7154
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.

Research & Development

The Company, through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. conducts in-house research, development and testing of its Invisicare® polymer delivery vehicles, and a variety of compositions which incorporate them. In addition, where appropriate for validation and independent verification of marketing claims, it utilizes FDA-registered independent laboratories with extensive qualifications for carrying out investigative product studies, utilizing protocols incorporating Good Lab Practice and Good Clinical Practice ("GLP/GCP") standards.

To date, both in-house and through recognized independent laboratories, Skinvisible has extensively testing including:
  • Persistence (Duration of Action);
  • Adherence to Skin's External Surface;
  • Desorption Studies;
  • Atomic Force Microscopy;
  • Permeation Studies;
  • Safety & Skin Sensitivity;
  • Skin Moisturizing Ability;
  • Toxicology; and
  • Product Stability & Aged Product Bio-Activity.
Sunscreen Testing:
Clinical tests performed by Suncare Research Laboratories revealed that Skinvisible's sunscreen composition, developed with an Invisicare® polymer delivery vehicle, produced successful results which allow labelling as "Very Water Resistant" in accordance with FDA Final Sunscreen Monograph requirements. In addition, Skinvisible's sunscreen formulations received a "broad spectrum" designation and was granted a patent from the United States Patent and Trademark Office for "Sunscreen Composition With Enhanced UVA Absorber Stability and Methods", Skinvisible has developed three sunscreen formulations using avobenzone; SPF 15, 30 and 50. Skinvisible's sunscreen formulation has an unprecedented eight hours of photostability, a unique advantage for everyone who uses sunscreens and works or plays outdoors.


  Granted Patents & Trademarks
  Technology Overview
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.